Page last updated: 2024-12-07

11-(dansylamino)undecanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

11-(dansylamino)undecanoic acid, also known as dansyl-undecanoic acid, is a fluorescent probe used in various research areas, including biochemistry, cell biology, and materials science. It is synthesized through a reaction between dansyl chloride and 11-aminoundecanoic acid. The dansyl group provides fluorescence properties, while the undecanoic acid chain allows for anchoring to various biomolecules or surfaces. This compound is particularly useful for studying membrane dynamics, protein-lipid interactions, and cellular processes. Its fluorescence properties enable researchers to track the movement and localization of tagged molecules within cells or biological systems. Additionally, its hydrophobic nature allows for interactions with lipid membranes, making it suitable for studying membrane structure and function.'

Cross-References

ID SourceID
PubMed CID122016
CHEBI ID186256
SCHEMBL ID591663
MeSH IDM0153645

Synonyms (26)

Synonym
dauda
11-(dansylamino)undecanoic acid
dauda-11
73025-02-2
11-((5-dimethylaminonaphthalene-1-sulfonyl)amino)undecanoic acid
undecanoic acid, 11-(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino)-
11-[5-(dimethylamino)-1-naphthalenesulfonylamino]undecanoic acid, bioreagent, suitable for fluorescence, >=98.0% (tlc)
11-[[5-(dimethylamino)naphthalen-1-yl]sulonylamino]undecanoic acid
CHEBI:186256
11-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]undecanoic acid
11D ,
11-({[5-(dimethylamino)naphthalen-1-yl]sulfonyl}amino)undecanoic acid
11-[5-(dimethylamino)-1-naphthalenesulfonylamino]undecanoic acid
FT-0607206
AKOS015893926
undecanoic acid,11-[[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]amino]-
SCHEMBL591663
DTXSID90223302
bdbm153300
mfcd00467271
11-(5-(dimethylamino)naphthalene-1-sulfonamido)undecanoic acid
11-(dansylamino) undecanoic acid
Q27451608
MS-27790
CS-0079721
HY-120959
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
sulfonic acid derivative
naphthalenesAny benzenoid aromatic compound having a skeleton composed of two ortho-fused benzene rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty acid-binding protein, intestinalHomo sapiens (human)Ki0.30000.30005.48149.4000AID1801103
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty acid-binding protein, intestinalHomo sapiens (human)Kd0.36000.36003.31757.2000AID1801104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
fatty acid metabolic processFatty acid-binding protein, intestinalHomo sapiens (human)
long-chain fatty acid transportFatty acid-binding protein, intestinalHomo sapiens (human)
intestinal lipid absorptionFatty acid-binding protein, intestinalHomo sapiens (human)
fatty acid transportFatty acid-binding protein, intestinalHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
long-chain fatty acid transmembrane transporter activityFatty acid-binding protein, intestinalHomo sapiens (human)
fatty acid bindingFatty acid-binding protein, intestinalHomo sapiens (human)
protein bindingFatty acid-binding protein, intestinalHomo sapiens (human)
long-chain fatty acid bindingFatty acid-binding protein, intestinalHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolFatty acid-binding protein, intestinalHomo sapiens (human)
microvillusFatty acid-binding protein, intestinalHomo sapiens (human)
apical cortexFatty acid-binding protein, intestinalHomo sapiens (human)
cytosolFatty acid-binding protein, intestinalHomo sapiens (human)
nucleusFatty acid-binding protein, intestinalHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1801104ITC Titration from Article 10.1021/cb5005178: \\Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.\\2014ACS chemical biology, Nov-21, Volume: 9, Issue:11
Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.
AID1801103Fluorophore Displacement Assay from Article 10.1021/cb5005178: \\Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.\\2014ACS chemical biology, Nov-21, Volume: 9, Issue:11
Characterization of two distinct modes of drug binding to human intestinal fatty acid binding protein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.63)18.7374
1990's18 (47.37)18.2507
2000's11 (28.95)29.6817
2010's8 (21.05)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.26 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index5.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]